JP2015511952A5 - - Google Patents

Download PDF

Info

Publication number
JP2015511952A5
JP2015511952A5 JP2014559259A JP2014559259A JP2015511952A5 JP 2015511952 A5 JP2015511952 A5 JP 2015511952A5 JP 2014559259 A JP2014559259 A JP 2014559259A JP 2014559259 A JP2014559259 A JP 2014559259A JP 2015511952 A5 JP2015511952 A5 JP 2015511952A5
Authority
JP
Japan
Prior art keywords
triazine
isopropyl
pyrazolo
amine
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014559259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015511952A (ja
JP6182549B2 (ja
Filing date
Publication date
Priority claimed from EP12157751.4A external-priority patent/EP2634190A1/en
Application filed filed Critical
Publication of JP2015511952A publication Critical patent/JP2015511952A/ja
Publication of JP2015511952A5 publication Critical patent/JP2015511952A5/ja
Application granted granted Critical
Publication of JP6182549B2 publication Critical patent/JP6182549B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014559259A 2012-03-01 2013-03-01 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体 Active JP6182549B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12157751.4A EP2634190A1 (en) 2012-03-01 2012-03-01 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
EP12157751.4 2012-03-01
PCT/EP2013/054224 WO2013128028A1 (en) 2012-03-01 2013-03-01 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors

Publications (3)

Publication Number Publication Date
JP2015511952A JP2015511952A (ja) 2015-04-23
JP2015511952A5 true JP2015511952A5 (https=) 2017-08-03
JP6182549B2 JP6182549B2 (ja) 2017-08-16

Family

ID=47757629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014559259A Active JP6182549B2 (ja) 2012-03-01 2013-03-01 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体

Country Status (17)

Country Link
US (1) US9567345B2 (https=)
EP (2) EP2634190A1 (https=)
JP (1) JP6182549B2 (https=)
KR (1) KR101821452B1 (https=)
CN (1) CN104350054B (https=)
AU (1) AU2013224848B2 (https=)
BR (1) BR112014021189B1 (https=)
CA (1) CA2865946C (https=)
DK (1) DK2820020T3 (https=)
ES (1) ES2583231T3 (https=)
HU (1) HUE029264T2 (https=)
IL (1) IL234183A (https=)
MX (1) MX347359B (https=)
RU (1) RU2645347C2 (https=)
SG (1) SG11201405129RA (https=)
WO (1) WO2013128028A1 (https=)
ZA (1) ZA201406078B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201403093D0 (en) 2014-02-21 2014-04-09 Cancer Rec Tech Ltd Therapeutic compounds and their use
CN106458990B (zh) 2014-04-04 2019-06-07 希洛斯医药品股份有限公司 细胞周期蛋白依赖性激酶7(cdk7)的抑制剂
EP3129371B1 (en) * 2014-04-05 2020-07-29 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
JP6690543B2 (ja) 2014-10-31 2020-04-28 宇部興産株式会社 置換ジヒドロピロロピラゾール化合物
CN107530329B (zh) * 2015-03-09 2021-10-08 奥瑞基尼探索技术有限公司 用作CDK抑制剂的吡唑并[1,5-a][1,3,5]三嗪和吡唑并[1,5-a]嘧啶衍生物
CA2989519C (en) 2015-06-15 2023-09-26 Ube Industries, Ltd. Substituted dihydropyrrolopyrazole derivative
CN107949563B (zh) * 2015-06-24 2020-06-05 库洛维公司 治疗中有用的吡唑并[1,5-a]三嗪-4-胺衍生物
BR112019004935A2 (pt) 2016-09-13 2019-06-04 Allergan, Inc. composições de toxina clostridial não proteíca estabilizada
CN106432249B (zh) * 2016-09-30 2018-12-04 陕西科技大学 一类吡咯并[2,1-f][1,2,4]三嗪母核化合物的合成及其医药用途
WO2019032720A1 (en) 2017-08-09 2019-02-14 Sanford Burnham Prebys Medical Discovery Institute APELIN RECEPTOR AGONISTS AND METHODS OF USE
GB201715194D0 (en) 2017-09-20 2017-11-01 Carrick Therapeutics Ltd Compounds and their therapeutic use
IL276013B2 (en) * 2018-01-17 2024-03-01 Glaxosmithkline Ip Dev Ltd Pi4kiiibeta inhibitors
EP3774809A1 (en) * 2018-04-11 2021-02-17 Qurient Co. Ltd. Pharmaceutically active pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives
US12606561B2 (en) 2018-04-11 2026-04-21 Qurient Co., Ltd. Substituted pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
EP3774810A1 (en) 2018-04-11 2021-02-17 Qurient Co. Ltd. Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase
US12022832B2 (en) 2018-09-12 2024-07-02 The Governing Council Of The University Of Toronto Compounds and methods for treating nematode infections
US11517568B2 (en) 2018-09-12 2022-12-06 The Governing Council Of The University Of Toronto Compounds and methods for treating nematode infections
CN113677346A (zh) 2018-11-01 2021-11-19 希洛斯医药品股份有限公司 周期蛋白依赖性激酶7(cdk7)的抑制剂
US12304913B2 (en) 2018-11-14 2025-05-20 Ube Industries, Ltd. Dihydropyrrolopyrazole derivative
CN110101703B (zh) * 2019-05-06 2021-06-11 暨南大学 Cdk7抑制剂在制备溃疡性结肠炎或结肠癌药物的应用
RU2713152C1 (ru) * 2019-08-30 2020-02-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения хронической аллергической крапивницы на фоне описторхоза
TW202146416A (zh) * 2019-12-11 2021-12-16 德商拜耳廠股份有限公司 吡唑并三𠯤
GB201918541D0 (en) * 2019-12-16 2020-01-29 Carrick Therapeutics Ltd Therapeutic compounds and their use
CN110950871B (zh) * 2019-12-25 2022-05-17 陕西师范大学 2-取代-4-芳氨基吡唑并三嗪衍生物及制备抗肿瘤药物的应用
CN116964061A (zh) * 2020-12-21 2023-10-27 詹森药业有限公司 作为细胞周期蛋白依赖性激酶7(cdk7)抑制剂的三环嘧啶
WO2022182918A1 (en) * 2021-02-25 2022-09-01 Icahn School Of Medicine At Mount Sinai Methods for inhibiting inflammation and progression of atherosclerotic plaques and cardiovascular events in patients with cerebro- and cardio-vascular disease
US20240254138A1 (en) * 2021-03-09 2024-08-01 Janssen Pharmaceutica Nv Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors
US20250042903A1 (en) * 2021-06-17 2025-02-06 H. Lee Moffitt Cancer Center And Research Institute, Inc. Triazine inhibitors of cyclin-dependent kinases
WO2023001061A1 (en) * 2021-07-17 2023-01-26 Jingrui Biopharma Co., Ltd. Cdk7 selective inhibitors as anticancer agents
AU2022318251A1 (en) 2021-07-29 2024-01-25 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
US20250019382A1 (en) * 2021-11-23 2025-01-16 Origenis Gmbh Novel inhibitors of cyclin-dependent kinases
CN114181217B (zh) * 2022-01-10 2022-12-27 陕西师范大学 吡唑并[1,5-a][1,3,5]三嗪衍生物及其盐和在制备抗癌药物中的应用
WO2023175173A1 (en) * 2022-03-18 2023-09-21 Qurient Co., Ltd. Cdk7 inhibitors for antiviral treatment
CN120712267A (zh) * 2023-02-21 2025-09-26 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US615968A (en) 1898-12-13 Apparatus for treating ores
HUP0200535A3 (en) * 1999-02-01 2002-11-28 Cv Therapeutics Inc Palo Alto 2,6,9-trisubstituted purine derivatives inhibitors of cyclin dependent kinase 2 and ikappa-b-alpha and pharmaceutical compositions containing them
US7119200B2 (en) 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PE20051128A1 (es) 2004-02-25 2006-01-16 Schering Corp Pirazolotriazinas como inhibidores de quinasa
CZ302122B6 (cs) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující
FR2943058B1 (fr) * 2009-03-11 2011-06-03 Centre Nat Rech Scient Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique.
CZ302711B6 (cs) * 2009-06-03 2011-09-14 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-hydroxybenzylamino)purinu, jejich použití jako léciva a farmaceutické prípravky tyto slouceniny obsahující

Similar Documents

Publication Publication Date Title
JP2015511952A5 (https=)
TWI762939B (zh) Btk抑制劑環衍生物及其製備方法和藥學上的應用
AU2021236451B2 (en) P2X7 modulators
AU2019382642B2 (en) GLP-1R agonists and uses thereof
JP6182549B2 (ja) 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体
AU2020285336B2 (en) Amino quinazoline derivatives as P2X3 inhibitors
TWI243820B (en) Pyrrolo[2,3-d]pyrimidine compounds and pharmaceutical composition containing the same
ES2294189T3 (es) Derivados de pirazolopirimidinona que tienen accion inhibidora de pde7.
AU2018237123B2 (en) Bruton's tyrosine kinase inhibitors
CA2754330A1 (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
AU2006279525A1 (en) Monocyclic and bicyclic compounds and methods of use
KR20070009699A (ko) 프롤린 유도체 및 그의 다이펩티딜 펩티다제-iv저해제로서의 용도
MX2011004211A (es) Derivados de sulfonamido pirimidina y triazina como inhibidores de receptor de bradiquinina b1 (b1r) para tratamiento de dolor.
BR102015024618A2 (pt) compostos inibidores de quinase de ligação de tank
DK2969000T3 (en) NEW CONNECTIONS
FI94526C (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsol-2-yyli- ja imidatso/4,5-b/pyridin-2-yyli-amino- ja -metyyli-1-piperidinyylietyylijohdannaisten valmistamiseksi
KR20230051500A (ko) Alk5 억제제로서 피리다진일 아미노 유도체
WO2023154124A1 (en) Acylated heterocyclic quinazoline derivatives as inhibitors of erbb2
BR112021003652A2 (pt) novo derivado de amina heterocíclica e composição farmacêutica compreendendo o mesmo
KR20110028445A (ko) 퇴행성 및 염증성 질병의 치료에 유용한 축합된 피라진 화합물
JP2024534169A (ja) Egfr阻害剤としての置換アミノピリジン化合物
JP2025020216A (ja) Dnaポリメラーゼiiic阻害剤及びその使用
EP3827005B1 (en) Pyridopyrimidines as histamine h4-receptor inhibitors
ES2771151T3 (es) Derivados de piperidina como inhibidor de señalización wnt
Oboh Optimization of Triazolopyridazines and PI4k Inhibitors as Potential Treatments for Cryptosporidiosis